Cargando…

The Impact of Prostate Cancer Upgrading and Upstaging on Biochemical Recurrence and Cancer-Specific Survival

Background and Objectives: Significant numbers of prostate cancer (PCa) patients experience tumour upgrading and upstaging between prostate biopsy and radical prostatectomy (RP) specimens. The aim of our study was to investigate the role of grade and stage increase on surgical and oncological outcom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bakavičius, Arnas, Drevinskaitė, Mingailė, Daniūnaitė, Kristina, Barisienė, Marija, Jarmalaitė, Sonata, Jankevičius, Feliksas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074013/ https://www.ncbi.nlm.nih.gov/pubmed/32033148 http://dx.doi.org/10.3390/medicina56020061

Ejemplares similares

Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging
por: Bakavicius, Arnas, et al.
Publicado: (2019)

Promoter Methylation of PRKCB, ADAMTS12, and NAALAD2 Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence
por: Daniunaite, Kristina, et al.
Publicado: (2021)

The utility of urine-circulating miRNAs for detection of prostate cancer
por: Stuopelyte, Kristina, et al.
Publicado: (2016)

Decreased expression of MT1E is a potential biomarker of prostate cancer progression
por: Demidenko, Rita, et al.
Publicado: (2017)

Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection
por: Barisiene, Marija, et al.
Publicado: (2020)

Frequent down-regulation of ABC transporter genes in prostate cancer
por: Demidenko, Rita, et al.
Publicado: (2015)

Clinical Significance of ADAMTS19, BMP7, SIM1, and SFRP1 Promoter Methylation in Renal Clear Cell Carcinoma
por: Kubiliute, Raimonda, et al.
Publicado: (2021)

Urinary DNA as a Tool for Germline and Somatic Mutation Detection in Castration-Resistant Prostate Cancer Patients
por: Januskevicius, Tomas, et al.
Publicado: (2023)

Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
por: Bosas, Paulius, et al.
Publicado: (2021)

Malignant mixed epithelial and stromal tumour of the kidney: a case report and a literature review
por: Bakavičius, Arnas, et al.
Publicado: (2018)

Treatment of recurrent stress urinary incontinence in women: comparison of treatment results for different surgical techniques
por: Cerniauskiene, Ausra, et al.
Publicado: (2014)

LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer
por: Vezelis, Alvydas, et al.
Publicado: (2021)

Complications after male adjustable suburethral sling implantation
por: Cerniauskiene, Ausra, et al.
Publicado: (2020)

Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients
por: Flammia, Rocco S., et al.
Publicado: (2022)

Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy
por: Gao, Yuan, et al.
Publicado: (2016)

Pathological upgrading and upstaging at radical prostatectomy in Jamaican men with low-risk prostate cancer
por: Morrison, Belinda F, et al.
Publicado: (2019)

Retrospective cohort study of androgen deprivation therapy and the risk of diabetes in men with prostate cancer in Lithuania
por: Drevinskaite, Mingaile, et al.
Publicado: (2021)

Upgrading and upstaging of low-risk prostate cancer among Korean patients: a multicenter study
por: Hwang, Insang, et al.
Publicado: (2015)

Comparative rates of upstaging and upgrading in Caucasian and Korean prostate cancer patients eligible for active surveillance
por: Jeon, Hwang Gyun, et al.
Publicado: (2017)

Association between Androgen Deprivation Therapy and the Risk of Inflammatory Rheumatic Diseases in Men with Prostate Cancer: Nationwide Cohort Study in Lithuania
por: Drevinskaite, Mingaile, et al.
Publicado: (2022)

Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line
por: Kubiliute, Raimonda, et al.
Publicado: (2021)

A Population-Based Analysis of Incidence, Mortality, and Survival in Testicular Cancer Patients in Lithuania
por: Drevinskaite, Mingaile, et al.
Publicado: (2019)

Analysis of Intrinsic Breast Cancer Subtypes: The Clinical Utility of Epigenetic Biomarkers and TP53 Mutation Status in Triple-Negative Cases
por: Sadzeviciene, Ieva, et al.
Publicado: (2022)

Letter to the Editor: No immunophenotyping in peripheral blood of prostate cancer patients treated with neoadjuvant Rituximab?
por: Bosas, Paulius, et al.
Publicado: (2020)

The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance
por: Murray, Nigel P, et al.
Publicado: (2017)

Prostate cancer solitary metastasis to anal canal: case report and review of literature
por: Dulskas, Audrius, et al.
Publicado: (2019)

Incidence, mortality and survival trends of penile cancer in Lithuania 1998–2017
por: Drevinskaite, Mingaile, et al.
Publicado: (2023)

Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance
por: Ferro, Matteo, et al.
Publicado: (2016)

Lung cancer upstaging due to the COVID-19 pandemic
por: Vella, Claire, et al.
Publicado: (2021)

Malignant mesothelioma of the tunica vaginalis testis: a rare case and review of literature
por: Drevinskaite, Mingaile, et al.
Publicado: (2020)

Old men with prostate cancer have higher risk of Gleason score upgrading and pathological upstaging after initial diagnosis: a systematic review and meta-analysis
por: Wang, Xiaochuan, et al.
Publicado: (2021)

No detrimental effect of a positive family history on postoperative upgrading and upstaging in men with low risk and favourable intermediate-risk prostate cancer: implications for active surveillance
por: Herkommer, Kathleen, et al.
Publicado: (2020)

Determination of Whether Apex or Non-Apex Prostate Cancer Is the Best Candidate for the Use of Prostate-Specific Antigen Density to Predict Pathological Grade Group Upgrading and Upstaging after Radical Prostatectomy
por: Huang, Cong, et al.
Publicado: (2023)

Safety, Pharmacokinetic and Pharmacodynamic Evaluation of Teverelix for the Treatment of Hormone-Sensitive Advanced Prostate Cancer: Phase 2 Loading-Dose-Finding Studies
por: MacLean, Carol M., et al.
Publicado: (2023)

Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer
por: Brant, Aaron, et al.
Publicado: (2022)

Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy
por: Vėželis, Alvydas, et al.
Publicado: (2021)

US "likely to upstage CERN accelerator"
por: Turney, J E
Publicado: (1984)

The dilemma of partial nephrectomy and surgical upstaging
por: dos Reis, Rodolfo Borges, et al.
Publicado: (2022)

CD8+ Cell Density Gradient across the Tumor Epithelium–Stromal Interface of Non-Muscle Invasive Papillary Urothelial Carcinoma Predicts Recurrence-Free Survival after BCG Immunotherapy
por: Drachneris, Julius, et al.
Publicado: (2023)

Future Screening Prospects for Ovarian Cancer
por: Žilovič, Diana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2k48dfrnglgod20vdb5j9f8c96